NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed rule on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Our comments focus on the role of consumers in identification, development, and endorsement of quality measures. As health care delivery and payment transition ...

NCCS joined with patient advocacy organizations in the Cancer Leadership Council (CLC) in submitting comments to the Reagan-Udall Foundation regarding the Draft Project Proposal for the Expanded Access Navigator for Individual Patient Access. In our letter, we commend the revisions to guidance documents, FDA educational materials, and the FDA website ...

In 1992, Congress passed the first Prescription Drug User Fee Act (PDUFA), a law that allows the Food and Drug Administration (FDA) to collect fees from drug companies that apply to the FDA for approval to market their drugs for specific medical conditions, e.g., a chemotherapy drug for ALK-positive lung ...

NCCS joined with patient advocacy organizations in the Cancer Leadership Council (CLC) in submitting comments to the Centers for Medicare and Medicaid Services (CMS) on its proposed Part B drug payment demonstration project. Over many years, the CLC has advocated reforms in Medicare reimbursement for cancer care, to support the ...

The Centers for Medicare and Medicaid Services (CMS) announced that they are postponing the release of their Hospital Compare Star Ratings. This is an unfortunate delay, as these ratings will serve as a valuable tool for cancer survivors and their families to have the information necessary to make informed decisions ...

NCCS recently submitted comments on the Senate Finance Committee's "Bipartisan Chronic Care Working Group Policy Options Document" in response to the working group's request for comments on possible policy options outlined in its report. Formed in May 2015, the working group is seeking ideas on how Medicare can improve the ...

NCCS submitted comments to the Centers for Medicare and Medicaid Services (CMS) in response to its request for feedback on the implementation key provisions of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Specifically, we offered comments on alternative payment models for cancer care as part of the ...

NCCS submitted letters to the Centers for Medicare and Medicaid Services (CMS) on its proposed revisions to the Medicare physician fee schedule for calendar year 2016. In our letter, NCCS commended CMS for its efforts to enhance comprehensive care management for certain Medicare beneficiaries.  Through improvements in fee-for-service payments and various ...

NCCS recently submitted comments to the American Society for Clinical Oncology (ASCO) on its proposed value framework. In June, ASCO published a draft of the framework, "A Conceptual Framework to Assess the Value of Cancer Treatment Options," in the Journal of Clinical Oncology and solicited feedback from stakeholders. ASCO described ...

What Caught Our Eye (WCOE) Each week, we recap the cancer policy articles, studies, and stories that caught our attention. Supreme Court decision is good news for cancer patients who need help purchasing health insurance. #SCOTUS #KingvBurwell— Shelley Fuld Nasso (@sfuldnasso) June 25, 2015 Check out this blog post about yesterday's #PACTAct ...